What are the absolute contraindications to heparin infusion?

Absolute Contraindications to Heparin Infusion

Heparin infusion is absolutely contraindicated in patients with history of heparin-induced thrombocytopenia (HIT), known hypersensitivity to heparin or pork products, uncontrolled active bleeding, and when suitable blood coagulation tests cannot be performed at appropriate intervals. 1

Detailed List of Absolute Contraindications

1. Heparin-Induced Thrombocytopenia (HIT)

• History of HIT or heparin-induced thrombocytopenia with thrombosis (HITT) 1
• Any administration of heparin is strictly contraindicated in patients with confirmed HIT, including heparin locks, catheter flushes, or routine administration 2
• The risk of recurrent HIT with re-exposure can lead to severe thrombotic complications and increased mortality

2. Hypersensitivity Reactions

• Known hypersensitivity to heparin or pork products 1
• History of anaphylactoid reactions to heparin preparations

3. Uncontrolled Active Bleeding

• Active major bleeding at any site, tissue, or organ 1
• Exception: When bleeding is due to disseminated intravascular coagulation (DIC), heparin may still be considered 1

4. Inability to Monitor

• Situations where suitable blood coagulation tests (e.g., whole blood clotting time, partial thromboplastin time) cannot be performed at appropriate intervals 1
• This contraindication applies specifically to full-dose heparin therapy; low-dose heparin generally doesn't require this level of monitoring

High-Risk Scenarios Requiring Caution

While not absolute contraindications, the following conditions require extreme caution when considering heparin infusion:

• Severe thrombocytopenia (platelets <50,000/mcL) 3, 4
• Uncontrolled arterial hypertension (systolic >200 mmHg, diastolic >110 mmHg) 3
• Severe renal impairment 3, 5
• Liver failure with elevated INR (>1.5) 3
• Recent central nervous system bleeding or high-risk intracranial/spinal lesions 4
• Recent spinal anesthesia or lumbar puncture 4
• Recent major surgery with high bleeding risk 4

Alternative Anticoagulation Options

When heparin is contraindicated but anticoagulation is necessary:

1. Direct Thrombin Inhibitors:

   • Bivalirudin - preferred for cardiac surgery when needed 2, 6
   • Argatroban - preferred in renal impairment 2, 5

2. For HIT patients requiring cardiac surgery:

   • Antiplatelet agents (tirofiban, cangrelor) combined with heparin for specific cardiac procedures 2, 6
   • Bivalirudin is the preferred alternative for cardiac surgery with cardiopulmonary bypass 2

3. For renal replacement therapy in HIT:

   • Citrate or argatroban are preferred for circuit anticoagulation 2

4. For mechanical thromboprophylaxis:

   • Intermittent pneumatic compression devices when pharmacological prophylaxis is contraindicated 7, 8

Monitoring Recommendations

• All patients receiving heparin should have baseline platelet count before starting treatment 9
• For patients with previous heparin exposure within 100 days, obtain baseline platelet count and repeat 24 hours after starting heparin 9
• For patients on unfractionated heparin, monitor platelet counts every other day from days 4-14 9
• If platelet count falls by ≥50% or below normal range, or if new thrombosis develops between days 4-14, consider HIT and assess clinically 9

Clinical Pitfalls to Avoid

• Don't delay alternative anticoagulation when HIT is strongly suspected - waiting for laboratory confirmation can lead to thrombotic complications 9
• Avoid warfarin in acute HIT as it can worsen hypercoagulability by depleting protein C 10
• Don't administer prophylactic platelets to patients with HIT as this can worsen thrombotic risk 9
• Remember that HIT can present with delayed onset, even after heparin has been discontinued 10
• Recognize that thrombotic complications in HIT can be severe and include venous and arterial thrombosis, limb ischemia, and skin necrosis 10

When heparin is absolutely contraindicated but anticoagulation is necessary, prompt consultation with hematology is recommended to determine the most appropriate alternative anticoagulant based on the specific clinical scenario.